Filing Details

Accession Number:
0001179110-16-022969
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-12 16:25:17
Reporting Period:
2016-04-08
Filing Date:
2016-04-12
Accepted Time:
2016-04-12 16:25:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456804 G Michael Howley C/O Abiomed, Inc.
22 Cherry Hill Drive
Danvers MA 01923
Vp, Global Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2016-04-08 200 $10.03 52,668 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2016-04-08 200 $98.80 52,468 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-04-08 200 $0.00 200 $10.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,800 2011-06-03 2020-06-03 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to buy) $22.44 2013-05-22 2022-05-22 0 25,000 Direct
Common Stock Stock Option (Right to Buy) $23.15 2014-05-14 2023-05-14 0 25,000 Direct
Common Stock Stock Option (Right to Buy) $21.55 2015-05-14 2024-05-14 0 25,000 Direct
Common Stock Stock Option (Right to Buy) $66.25 2016-05-13 2025-05-13 0 5,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-05-22 0 25,000 Direct
2023-05-14 0 25,000 Direct
2024-05-14 0 25,000 Direct
2025-05-13 0 5,000 Direct
Footnotes
  1. Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  2. These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
  3. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  4. Sale of common stock pursuant to reporting owner's 10b5-1 plan.
  5. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $98.5950 and $99.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.